ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

ROQ Roquefort Therapeutics Plc

4.40
-0.10 (-2.22%)
18 Jun 2024 - Closed
Delayed by 15 minutes

Roquefort Therapeutics Financial Summary

The current ROQ market cap is 5.68M. The company's latest EPS is GBP -0.0135 and P/E is -3.26.

Year End 31 December 2023 202120222023
GBP (£)GBP (£)GBP (£)
Total Revenue 1,0000200k
Operating Income -916k-1.63M-1.93M
Net Income -916k-1.62M-1.75M
Year End 31 December 2023 202120222023
GBP (£)GBP (£)GBP (£)
Total Assets 4.56M7.77M6.09M
Total Liabilities 477k561k589k
Total Equity 4.08M7.21M5.5M

Cash Flow

Year End 31 December 2023 202120222023
GBP (£)GBP (£)GBP (£)
Operating -516k-1.58M-1.73M
Investing -606k-103k-53k
Financing 2.02M3.1M N/A
Market Cap 5.68M
Price to Earnings Ratio -3.26
Price to Sales Ratio 29.33
Price to Cash Ratio 10.48
Price to Book Ratio 1.03
Dividend Yield -

Share Statistics

Shares Outstanding 129.15M
Average Volume (1 week) 275.08k
Average Volume (1 Month) 356.88k
52 Week Change -37.14%
52 Week High 9.25
52 Week Low 4.00
Spread (Intraday) 0.2 (4.44%)

Company Info

Company Name Roquefort Therapeutics Plc
Address 85 great portland street
london W1W 7LT
Website https://www.roquefortplc.com
Industry cmp integrated sys design (7373)

Your Recent History

Delayed Upgrade Clock